Gennaro Pagano
Affiliations: | Cardiology | UNiversità degli Studi di Napoli Federico II |
Google:
"Gennaro Pagano"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brundin P, Svoboda H, Bonni A, et al. (2022) This is NOT the End for Immunotherapy in Parkinson's Disease - A Perspective from Early Drug Development Scientists. Journal of Parkinson's Disease |
| Pagano G, Taylor KI, Anzures-Cabrera J, et al. (2022) Trial of Prasinezumab in Early-Stage Parkinson's Disease. The New England Journal of Medicine. 387: 421-432 |
| Lipsmeier F, Taylor KI, Postuma RB, et al. (2022) Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease. Scientific Reports. 12: 12081 |
| Wilson H, Pagano G, Yousaf T, et al. (2022) Correction to: Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1). Journal of Neural Transmission (Vienna, Austria : 1996) |
| Pagano G, Boess FG, Taylor KI, et al. (2021) A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Frontiers in Neurology. 12: 705407 |
| Kremer T, Taylor KI, Siebourg-Polster J, et al. (2021) Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Ahamadi M, Mehrotra N, Hanan N, et al. (2021) A disease progression model to quantify the non-motor symptoms of Parkinson's disease in participants with leucine-rich repeat kinase 2 mutation. Clinical Pharmacology and Therapeutics |
| Wilson H, Pagano G, de Natale ER, et al. (2020) Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug-Naive Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Wilson H, Pagano G, Yousaf T, et al. (2019) Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1). Journal of Neural Transmission (Vienna, Austria : 1996) |
| Niccolini F, Wilson H, Giordano B, et al. (2019) Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson's disease. Bmc Neuroscience. 20: 55 |